AMH vs CPT Stock Comparison
AMH currently leads CPT in this stock comparison, with AIQ scores of 48 vs 44. The clearest difference is quality, while CPT has the stronger momentum profile.
What is the main difference between AMH and CPT?
AMH leads the current stock comparison as American Homes 4 Rent, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
American Homes 4 Rent vs Camden Property Trust
AMH leads
AMH leads by 4 AIQ points, primarily on Quality and Value.
Stable: 5 of 6 evidence groups support AMH, and its signal state is cleanly positive.
American Homes 4 Rent
Camden Property Trust
The Algovestiq AIQ Score currently favors AMH over CPT, 48 versus 44 as of Oct 21, 2026. AMH's advantage is driven primarily by stronger quality and value, while CPT holds the stronger momentum profile. AMH also shows the weaker technical structure relative to its 50-day moving average. 5 of 6 covered evidence groups favor AMH today, and the comparison is rated Stable on stability: the AIQ gap is narrow at 4 points. AMH lead: Stable — the AIQ differential has held near 4 points over 30 sessions.
Compare American Homes 4 Rent and Camden Property Trust across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AMH and CPT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality39 vs 29AMH +10
- Value45 vs 36AMH +9
- Momentum51 vs 55CPT +4
- Risk Resilience69 vs 72Even
5 of 6 evidence groups favor AMH. AMH’s edge is concentrated in quality and value; CPT keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +6
No signal started or stopped since the prior session; its 3 active signals are unchanged.
Largest factor move: Momentum +14
New signals
- BB Upper Band Breach — bearish, volatility, short horizon
AMH's lead narrowed by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — AMH and CPT both carry a full feed there.
The central trade-off
AMH (American Homes 4 Rent): the stronger current systematic profile, led by quality and value.
CPT (Camden Property Trust): the counter-case, on momentum.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AMHAMH on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AMHAMH on combined revenue and EPS growth.
Value
AMHAMH on the peer-relative Value factor, by 9 points.
Momentum
CPTCPT on the Momentum factor, by 4 points.
Lower downside
AMHAMH carries the lower 1-month annualized volatility.
Analyst upside
AMHAMH on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AMH | CPT | Note |
|---|---|---|---|
| Implied upside to target | +15% | +12.2% | AMH has more room |
| Target dispersion | +22.5% | +25.1% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 11 | 13 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
Dividend growth
| Dividend metric | AMH | CPT |
|---|---|---|
| 5Y dividend CAGR | 43.10% | 4.81% |
| 2020 regular DPS | $0.200 | $3.320 |
| 2025 regular DPS | $1.200 | $4.200 |
| Years increased | 5 | 4 |
| No cut in window | Yes | Yes |
| Cohort rank | #1 | #18 |
AMH grew its split-adjusted regular dividend faster over 2020–2025 — 43.10% a year against CPT's 4.81%. Neither company reduced its regular dividend in any year of the window.
Yield and payout ratio shown elsewhere on this page are current values, not part of the study window.
Split-adjusted regular dividends per share, 2020–2025, excluding special dividends. Research as of Sep 19, 2026.
AIQ Agreement Matrix
5 of 6 covered evidence groups favor AMH. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | AMH | 48 vs 44 |
| Fundamentals | AMHon balance | revenue growth -0.4% vs 1.2%; EPS growth -11.4% vs -55%; TTM ROE 6.9% vs 7.8%; gross margin 30.6% vs 22.3%; operating margin 25.3% vs 17.8% — AMH takes 3 of 5 decided legs, not all of them |
| Valuation | AMH | Value 45 vs 36 |
| Technicals | AMH | Price vs 50-day -3.4% vs -2.1%; vs 200-day -1.4% vs -6.1% |
| Risk Resilience | Even | Risk Resilience 69 vs 72 |
| Analyst expectations | AMH | Target upside 15% vs 12.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AMH and CPT and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is narrow at 4 points. (argues the conclusion is provisional)
- 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AMH.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20AMH lead: Stable — the AIQ differential has held near 4 points over 30 sessions.
- Today
- AMH +4
- 48 vs 44
- 7 sessions ago
- AMH +6
- 47 vs 41
- 30 sessions ago
- AMH +6
- 42 vs 36
- 90 sessions ago
- AMH +9
- 51 vs 42
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 0 bearish / 1 neutral
Only AMH
- Golden Cross Active — bullish, trend, long horizon (1.36%)
1 bullish / 4 bearish / 1 neutral, conflicted
Only CPT
- Death Cross Active — bearish, trend, long horizon (3.87%)
- BB Upper Band Breach — bearish, volatility, short horizon
- 52-Week Low Proximity — bearish, risk, long horizon (2.0%)
- Downtrend Structure Active — bearish, trend, long horizon
Both carry 2 more signals that do not separate them: Bollinger Band Squeeze, MACD Bullish Crossover.
CPT is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -0.71%, AIQ +1 points).
Price and the AIQ Score both moved up over the latest session (price +0.42%, AIQ +3 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CPT closes the Quality gap — currently 10 points behind, the largest single contributor to AMH's edge.
- 2CPT's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3AMH's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AMH leads on balance| Metric | AMH | CPT |
|---|---|---|
| Revenue growth (YoY) | -0.4% | 1.2% |
| EPS growth (YoY) | -11.4% | -55% |
| Gross margin | 30.6% | 22.3% |
| Operating margin | 25.3% | 17.8% |
| Return on equity (TTM) | 6.9% | 7.8% |
| Debt to equity | 0.76 | 1.28 |
Performance
Split across windows| Metric | AMH | CPT |
|---|---|---|
| 1 week (5 sessions) | 1.7% | 1.8% |
| 1 month (20 sessions) | -0.4% | 0.5% |
| 3 months (63 sessions) | -6.1% | -10.9% |
| 6 months (126 sessions) | 2.1% | -2.6% |
| Year to date | -2.9% | -9.4% |
| 1 year (252 sessions) | -4.5% | -2% |
Technicals
AMH has the stronger structure| Metric | AMH | CPT |
|---|---|---|
| RSI (14) | 60.1 | 63.5 |
| ADX (14) | 29.4 | 32.9 |
| Price vs 50-day | -3.4% | -2.1% |
| Price vs 200-day | -1.4% | -6.1% |
| Volatility (1M, annualized) | 15.2% | 16.6% |
Risk
Split| Metric | AMH | CPT |
|---|---|---|
| Beta | 0.02 | 0.08 |
| Sharpe ratio | -0.35 | -0.23 |
| Sortino ratio | -0.58 | -0.36 |
| Max drawdown | -17.9% | -18.5% |
| Current drawdown | -10.5% | -15.2% |
| Annualized volatility | 19.9% | 19.8% |
| Value at risk (95%) | -2% | -2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AMH or CPT?
On the Algovestiq AIQ Score, AMH is the stronger of the two as of Oct 21, 2026, scoring 48 against CPT's 44. The edge comes from quality and value. CPT is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AMH or CPT the better buy right now?
AMH carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor AMH over CPT?
The composite weights Quality, Value, Momentum and Risk Resilience. AMH leads Quality by 10 points; AMH leads Value by 9 points; CPT leads Momentum by 4 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AMH or CPT?
Analyst price targets imply +15% upside for AMH and +12.2% for CPT, so the Street currently favors AMH. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AMH or CPT?
AMH is the better-valued of the two on the peer-relative Value factor. AMH on the peer-relative Value factor, by 9 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AMH or CPT?
AMH on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AMH or CPT?
CPT on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AMH or CPT?
AMH is the more resilient of the two, so the other name carries the higher downside risk. AMH carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AMH more profitable than CPT?
The profitability evidence is mixed: gross margin 30.6% vs 22.3%; operating margin 25.3% vs 17.8%; ttm roe 6.9% vs 7.8%. AMH leads on two measures and CPT on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is AMH's lead over CPT getting stronger or weaker?
AMH lead: Stable — the AIQ differential has held near 4 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has not changed hands in that window.
What would change the AMH vs CPT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CPT closes the Quality gap — currently 10 points behind, the largest single contributor to AMH's edge; CPT's Death Cross Active resolves — a bearish trend rule currently active against it; AMH's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about AMH and CPT?
AMH: 2 bullish / 0 bearish / 1 neutral. CPT: 1 bullish / 4 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AMH is Golden Cross Active (bullish, long horizon). On CPT it is Death Cross Active (bearish, long horizon).
Compare AMH and CPT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.